Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38341
CAS Number:
609799-22-6
Tasimeltéon
Purity:
≥ 98 % (HPLC)
Synonym(s):
N -[[(1 R ,2 R )-2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]méthyl]propanamide, (1 R , 2 R )- N -[2-(2,3-Dihydrobenzofuran-4-yl)cyclopropylméthyl]propanamide
Documents
$192.29 /10 mg
Taille
Request Bulk Quote
Informations sur le produit

Tasimelteon is a novel compound recognized for its unique properties as a selective melatonin receptor agonist, primarily targeting the MT1 and MT2 receptors. This compound has garnered attention in the pharmaceutical industry for its potential applications in treating sleep disorders, particularly non-24-hour sleep-wake disorder, which is prevalent among individuals who are blind. By mimicking the natural hormone melatonin, Tasimelteon helps regulate circadian rhythms, promoting better sleep quality and overall well-being.

In addition to its therapeutic benefits, Tasimelteon is being explored for its role in various research applications, including studies on circadian biology and sleep regulation. Its specificity for melatonin receptors sets it apart from other sleep aids, offering a targeted approach with potentially fewer side effects. Researchers and healthcare professionals can leverage Tasimelteon to develop innovative treatments that address sleep-related issues, making it a valuable addition to the pharmacological landscape.

Numéro CAS 
609799-22-6
Formule moléculaire
C 15 H 19 NON 2
Poids moléculaire 
245.32
Point de fusion 
77 - 79 °C
Rotation optique 
-41 à -46 ° (C=1, CHCl3)
Informations générales
Numéro CAS 
609799-22-6
Formule moléculaire
C 15 H 19 NON 2
Poids moléculaire 
245.32
Point de fusion 
77 - 79 °C
Rotation optique 
-41 à -46 ° (C=1, CHCl3)
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Tasimelteon is widely utilized in research focused on:

  • Sleep Disorders: Primarily developed for the treatment of non-24-hour sleep-wake disorder, it helps individuals, especially those who are blind, to regulate their sleep patterns effectively.
  • Chronobiology Studies: Researchers use Tasimelteon to study circadian rhythms and their impact on various physiological processes, providing insights into how our internal clocks affect health.
  • Pharmaceutical Development: It serves as a model compound in the development of new sleep aids, allowing scientists to explore modifications that could enhance efficacy or reduce side effects.
  • Neuroscience Research: The compound is used to investigate the mechanisms of sleep regulation in the brain, contributing to a better understanding of sleep-related disorders.
  • Clinical Trials: Tasimelteon is involved in clinical research to evaluate its effectiveness compared to other sleep medications, helping to establish its place in therapy for sleep-related issues.

Citations